Pulmonary hypertension due to interstitial lung disease or chronic obstructive pulmonary disease: a patient experience study of symptoms and their impact on quality of life-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pulmonary hypertension due to interstitial lung disease or chronic obstructive pulmonary disease: a patient experience study of symptoms and their impact on quality of life

Published:2021-04 Issue:2 Volume:11 Page:1-9
ISSN:2045-8940
Container-title:Pulmonary Circulation
language:en
Short-container-title:Pulm. circ.

Author:

DuBrock Hilary M.¹^ORCID,Nathan Steven D.²,Reeve Bryce B.³,Kolaitis Nicholas A.⁴,Mathai Stephen C.⁵,Classi Peter M.⁶,Nelsen Andrew C.⁶,Olayinka‐Amao Bimpe⁷,Norcross Lindsey N.⁷,Martin Susan A.⁸^ORCID

Affiliation:

1. Division of Pulmonary and Critical Care MedicineMayo ClinicRochesterMNUSA

2. Inova Heart and Vascular InstituteFalls ChurchVAUSA

3. Department of Population Health SciencesDuke University School of MedicineDurhamNCUSA

4. Division of PulmonaryCritical Care, Allergy, and Sleep MedicineSan Francisco Medical CenterUniversity of CaliforniaSan FranciscoCAUSA

5. Division of Pulmonary and Critical Care MedicineJohns Hopkins University School of MedicineBaltimoreMDUSA

6. Global Medical Affairs, United TherapeuticsDurhamNCUSA

7. Patient‐Centered Outcomes AssessmentRTI Health SolutionsDurhamNCUSA

8. Patient‐Centered Outcomes AssessmentRTI Health SolutionsAnn ArborMIUSA

Funder

United Therapeutics Corporation

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1177/20458940211005641

Reference25 articles.

1. Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohort.;Strange G;Heart,2012

2. Increasing incidence and prevalence of World Health Organization Groups 1 to 4 pulmonary hypertension: a population‐based cohort study in Ontario, Canada;Wijeratne DT;. Circ Cardiovasc Qual Outcomes,2018

3. Haemodynamic definitions and updated clinical classification of pulmonary hypertension;Simonneau G;Eur Repir J,2019

4. Group III pulmonary hypertension: pulmonary hypertension associated with lung disease: epidemiology, pathophysiology, and treatment;Klinger JR.;Cardiol Clinics,2016

5. Pulmonary hypertension surveillance: United States, 2001 to 2010.;George MG;Chest,2014

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The European Voice of the Patient living with pulmonary hypertension associated with interstitial lung disease: Diagnosis, symptoms, impacts, and treatments;Pulmonary Circulation;2024-04

2. Using PAH‐SYMPACT to assess quality of life in patients with pulmonary hypertension associated with chronic lung disease;Pulmonary Circulation;2024-01

3. Unmasking a Silent Threat: Improving Pulmonary Hypertension Screening Methods for Interstitial Lung Disease Patients;Medicina;2023-12-28

4. Interstitial lung disease-associated pulmonary hypertension – what the future holds;Current Opinion in Pulmonary Medicine;2023-07-07

5. Pulmonary hypertension in interstitial lung disease and in chronic obstructive pulmonary disease: different entities?;Current Opinion in Pulmonary Medicine;2023-06-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3